Swiss Life Asset Management’s Avidity Biosciences RNAM Stock Holding History

Swiss Life Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,954	Closed	-$357K	–	1595
2025 Q4	$357K	Buy	4,954 +55	+1%	+$3.55K	﹤0.01%	940
2025 Q3	$213K	Buy	+4,899	New	+$198K	﹤0.01%	1085

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Swiss Life Asset Management's RNAM Position: Q1 2026 in Review

Swiss Life Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,954 shares — an estimated $357K sold.

Swiss Life Asset Management first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $357K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Swiss Life Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Swiss Life Asset Management sold 4,954 Avidity Biosciences shares in Q1 2026, an estimated $357K.
Swiss Life Asset Management first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
Swiss Life Asset Management's Avidity Biosciences position peaked at $357K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Swiss Life Asset Management's 13F filing for Q1 2026, filed 14 May 2026.